Chemical Entities of Biological Interest
2332 terms(s) returned
| Term Type: | Record: 201 to 250 of 2332 Records | Page: 5 of 47, First Previous Next Last | Show Records Per Page |
- (5S,8S,9R,10S)-selina-4(14),7(11)-diene-8,9-diol
- (5S,8S,9S,12R)-20-chloro-5,9-dihydroxy-12-methoxy-6,8,16-trimethyl-2-azabicyclo[16.3.1]docosa-1(21),6,13,15,18(22),19-hexaene-3,11-dione
- (5S,8S,9S,12R)-21-bromo-5,9-dihydroxy-12-methoxy-6,8,16-trimethyl-2-azabicyclo[16.3.1]docosa-1(21),6,13,15,18(22),19-hexaene-3,11-dione
- (5S,8S,9S,12R)-21-chloro-5,9,20-trihydroxy-12-methoxy-6,8,16-trimethyl-2-azabicyclo[16.3.1]docosa-1(21),6,13,15,18(22),19-hexaene-3,11-dione
- (5S,8S,9S,12R)-21-chloro-5,9-dihydroxy-12,20-dimethoxy-6,8,16-trimethyl-2-azabicyclo[16.3.1]docosa-1(21),6,13,15,18(22),19-hexaene-3,11-dione
- (5S,8S,9S,12R)-21-chloro-5,9-dihydroxy-12-methoxy-6,8,16-trimethyl-2-azabicyclo[16.3.1]docosa-1(21),6,13,15,18(22),19-hexaene-3,11-dione
- (5S,9R)-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.01,10.04,9]hexadec-14-ene-5-carboxylic acid
- (5S,9R,10S,11R,13R,14R,15S,17R)-11,15-dihydroxy-17-[(2S)-6-hydroxy-6-methyl-5-oxoheptan-2-yl]-10,13-dimethyl-1,2,4,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
- (5S,9S,10S,13E)-labda-7,13-dien-15-yl diphosphate
- (5S,9S,10S,13E)-labda-7,13-dien-15-yl diphosphate(3-)
- (5S,S)-5-methyl-3-(2-methylbutyl)furan-2(5H)-one
- (5Z)-13-carboxytridec-5-enoylcarnitine
- (5Z)-3-(2-chloroethyl)-5-[[(1S)-cyclohex-2-en-1-yl]methylidene]-4-methylpyrrol-2-one
- (5Z)-3-(3,4-dihydroxyphenyl)-5-[(3,4-dihydroxyphenyl)methylidene]-5-oxo-2,5-dihydrofuran-3-olate
- (5Z)-3-(4-chlorophenyl)-4-hydroxy-5-(naphthalen-1-ylmethylidene)furan-2(5H)-one
- (5Z)-3-benzyl-5-[(2-hydroxy-3-nitrophenyl)methylidene]-2-thioxo-1,3-thiazolidin-4-one
- (5Z)-3-oxotetradecenoyl-CoA
- (5Z)-3-oxotetradecenoyl-CoA(4-)
- (5Z)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione
- (5Z)-5-[(2,2-difluoro-1,3-benzodioxol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione
- (5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-{[(S)-(4-fluorophenyl)(1H-tetrazol-5-yl)methyl]amino}-1,3-thiazol-4(5H)-one
- (5Z)-7-[(1S,5E)-5-[(2E)-Oct-2-en-1-ylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoylcarnitine
- (5Z)-hexadec-5-enoyl-CoA(4-)
- (5Z)-oct-5-enal
- (5Z)-octenoyl-CoA(4-)
- (5Z)-tetradecenoyl-CoA
- (5Z)-tetradecenoyl-CoA(4-)
- (5Z)-tetradecenoylcarnitine
- (5Z,11Z,14Z)-8,9-dihydroxyicosatrienoate
- (5Z,11Z,14Z)-8,9-dihydroxyicosatrienoic acid
- (5Z,11Z,14Z)-icosatrienoate
- (5Z,11Z,14Z)-icosatrienoic acid
- (5Z,11Z,14Z)-icosatrienoyl-CoA
- (5Z,11Z,14Z)-icosatrienoyl-CoA(4-)
- (5Z,11Z,14Z,17Z)-8,9-epoxyicosatetraenoate
- (5Z,11Z,14Z,17Z)-icosatetraenoate
- (5Z,11Z,14Z,17Z)-icosatetraenoic acid
- (5Z,11Z,14Z,17Z)-icosatetraenoyl-CoA
- (5Z,11Z,14Z,17Z)-icosatetraenoyl-CoA(4-)
- (5Z,7E)-(1R,2R,3R)-3-(hydroxy-propyl)-19-nor-9,10-seco-5,7-cholestadien-1,3,25-triol
- (5Z,7E)-(1S,3R)-1,3-dihydroxy-9,10-seco-5,7,10(19)-cholestatrien-22-one
- (5Z,7E)-(1S,3R)-21-nor-20-oxa-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
- (5Z,7E)-(1S,3R)-24,24-difluoro-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatrien-1,3,25-triol
- (5Z,7E)-(3S)-26,26,26-trifluoro-27-nor-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol
- (5Z,7E)-(3S)-3-hydroxy-9,10-seco-5,7,10(19)-cholatrien-24-oic acid
- (5Z,7E)-9,10-seco-5,7,10(19)-cholestatriene
- (5Z,7E,22E)-(1S,3R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3-diol
- (5Z,7E,9E,14Z,17Z)-icosapentaenoate
- (5Z,7E,9E,14Z,17Z)-icosapentaenoic acid
- (5Z,8R,9E,11Z,14Z,17Z)-8-hydroperoxyicosapentaenoate
